National Bank of Canada
CRBU icon

National Bank of Canada’s Caribou Biosciences CRBU Stock Holding History

National Bank of Canada’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,444
Closed -$3.88K – 2811
2024
Q2 		$3.88K Hold
2,444
– – ﹤0.01% 2316
2024
Q1 		$8.63K Hold
2,444
– – ﹤0.01% 2203
2023
Q4 		$13.6K Hold
2,444
– – ﹤0.01% 2102
2023
Q3 		$11K Buy
2,444
+1,113
+84% +$6.91K ﹤0.01% 2175
2023
Q2 		$4.25K Buy
1,331
+331
+33% +$1.49K ﹤0.01% 2375
2023
Q1 		$5.3K Hold
1,000
– – ﹤0.01% 2276
2022
Q4 		$6.28K Hold
1,000
– – ﹤0.01% 2284
2022
Q3 		$10K Sell
1,000
-2,500
-71% -$23.3K ﹤0.01% 2176
2022
Q2 		$19K Buy
+3,500
New +$26.8K ﹤0.01% 2088

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

National Bank of Canada's CRBU Position: Q3 2024 in Review

National Bank of Canada sold out of Caribou Biosciences (CRBU) in Q3 2024, closing a stake of 2,444 shares — an estimated $3.88K sold.

National Bank of Canada first reported a position in CRBU in Q2 2022 and held it in 9 quarters. The position peaked at $19K in Q2 2022. 129 funds tracked by Wall St. Rank hold CRBU as of Q3 2024.

  • National Bank of Canada reported no remaining Caribou Biosciences position as of Q3 2024 after selling out during the quarter.
  • National Bank of Canada sold 2,444 Caribou Biosciences shares in Q3 2024, an estimated $3.88K.
  • National Bank of Canada first reported a position in Caribou Biosciences in Q2 2022 and held it in 9 quarters.
  • National Bank of Canada's Caribou Biosciences position peaked at $19K in Q2 2022.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2024.

Based on National Bank of Canada's 13F filing for Q3 2024, filed 12 Nov 2024.